Fda Approval
-
{
- All
- News
- Videos
-
FDA Approves New Weight-Loss Pill For Use At Any Time Of Day
The US regulator has approved Eli Lilly's new oral weight-loss drug Foundayo through a fast-track process, offering a more convenient and potentially affordable alternative to injectable obesity treatments.
-
Once-Restricted Peptides May Make A Return: What This Means For Skin Care
The FDA announcement of the reclassification of 14 peptides marks a turning point for the skincare industry. Here is what it means, which peptides are going to be available for use, and why medical oversight is needed for safety.
-
Eight Sleep Bets Big on AI-Powered Predictive Sleep, Backed by $50 Million Funding
Eight Sleep, the New York-based sleep technology company, is planning to expand into the artificial intelligence (AI)-powered predictive sleep health space. The move comes after the startup raised $50 million (roughly Rs. 469.7 crore) in a funding round earlier this month. The company has announced that it is now exploring the sleep health space th...
-
Higher-Dose Wegovy Gets US Nod, Trials Show Over 20% Average Weight Loss, Says Drugmaker
Novo Nordisk said it plans to launch the new formulation, (semaglutide 7.2 mg), in the United States in April 2026.
-
Woman With Stage-3 Colorectal Cancer Recovers In Only 4 Months, Thanks To This New Therapy
Mrinali Dhembla, 27, diagnosed with stage-3 colorectal cancer and Lynch syndrome, recovers rapidly after receiving a dual immunotherapy regimen.
-
Hyderabad-Based Pharmaceutical Gets US Nod For Generic ADHD Drug: Why This Matters And What It Means
ADHD is a neurodevelopmental condition that affects both children and adults. It is characterised by symptoms such as difficulty concentrating, impulsive behaviour and hyperactivity.
-
First Oral Pill For Adults With Thalassemia Anaemia Gets Approval, Experts Hail It As Game Changer
The US Food and Drug Administrations (FDA) approval of the first-ever oral pill for anaemia in adults with thalassemia marks a historic milestone and can be a game changer in the management of the genetic blood disorder, said
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
Trump Asks Pregnant Women To Avoid This Painkiller Over Link To Autism
US President Donald Trump on Monday urged pregnant people not to take Tylenol over an unproven link to autism, and urged major changes to the standard vaccines given to babies.
-
Apple Watch Hypertension Tracking Feature Receives FDA Approval, Coming Next Week: Report
Apple’s hypertension detection feature will reportedly launch next week on the Apple Watch Series 11 and Watch Ultra 3 following FDA clearance, and will also be available on Series 9, Series 10, and Watch Ultra 2 models. Available in 150 countries, including the US, Hong Kong, and the EU, the feature uses the Apple Watch’s optical heart sensor ...
-
FDA Approves New Weight-Loss Pill For Use At Any Time Of Day
The US regulator has approved Eli Lilly's new oral weight-loss drug Foundayo through a fast-track process, offering a more convenient and potentially affordable alternative to injectable obesity treatments.
-
Once-Restricted Peptides May Make A Return: What This Means For Skin Care
The FDA announcement of the reclassification of 14 peptides marks a turning point for the skincare industry. Here is what it means, which peptides are going to be available for use, and why medical oversight is needed for safety.
-
Eight Sleep Bets Big on AI-Powered Predictive Sleep, Backed by $50 Million Funding
Eight Sleep, the New York-based sleep technology company, is planning to expand into the artificial intelligence (AI)-powered predictive sleep health space. The move comes after the startup raised $50 million (roughly Rs. 469.7 crore) in a funding round earlier this month. The company has announced that it is now exploring the sleep health space th...
-
Higher-Dose Wegovy Gets US Nod, Trials Show Over 20% Average Weight Loss, Says Drugmaker
Novo Nordisk said it plans to launch the new formulation, (semaglutide 7.2 mg), in the United States in April 2026.
-
Woman With Stage-3 Colorectal Cancer Recovers In Only 4 Months, Thanks To This New Therapy
Mrinali Dhembla, 27, diagnosed with stage-3 colorectal cancer and Lynch syndrome, recovers rapidly after receiving a dual immunotherapy regimen.
-
Hyderabad-Based Pharmaceutical Gets US Nod For Generic ADHD Drug: Why This Matters And What It Means
ADHD is a neurodevelopmental condition that affects both children and adults. It is characterised by symptoms such as difficulty concentrating, impulsive behaviour and hyperactivity.
-
First Oral Pill For Adults With Thalassemia Anaemia Gets Approval, Experts Hail It As Game Changer
The US Food and Drug Administrations (FDA) approval of the first-ever oral pill for anaemia in adults with thalassemia marks a historic milestone and can be a game changer in the management of the genetic blood disorder, said
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
Trump Asks Pregnant Women To Avoid This Painkiller Over Link To Autism
US President Donald Trump on Monday urged pregnant people not to take Tylenol over an unproven link to autism, and urged major changes to the standard vaccines given to babies.
-
Apple Watch Hypertension Tracking Feature Receives FDA Approval, Coming Next Week: Report
Apple’s hypertension detection feature will reportedly launch next week on the Apple Watch Series 11 and Watch Ultra 3 following FDA clearance, and will also be available on Series 9, Series 10, and Watch Ultra 2 models. Available in 150 countries, including the US, Hong Kong, and the EU, the feature uses the Apple Watch’s optical heart sensor ...
